A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian Subjects
2006 ◽
Vol 44
◽
pp. S208-S209
◽
Keyword(s):
2002 ◽
Vol 24
(10)
◽
pp. 1549-1560
◽
Keyword(s):
2020 ◽
Vol 20
(5)
◽
pp. 489-503
Keyword(s):
2013 ◽
Vol 34
(suppl 1)
◽
pp. P3321-P3321
◽
Keyword(s):